Sudden Cardiac Death News and Research

RSS

The term sudden cardiac death refers to natural death from cardiac causes, heralded by abrupt loss of consciousness within one hour of the onset of acute symptoms.

Children with attention deficit hyperactivity disorder should undergo heart tests before treatment with stimulant drugs

Children with attention deficit hyperactivity disorder (ADHD) should get careful cardiac evaluation and monitoring - including an electrocardiogram (ECG) - before treatment with stimulant drugs, a new American Heart Association statement recommends.

21 Apr 2008

Angina drug ranolazine potentially useful against heart rhythm disorders

A recently approved angina drug may also represent a powerful new treatment for a rare hereditary syndrome that places teens at risk for sudden cardiac death, according to research presented on April 1st at the 57th Annual Scientific Sessions of the American College of Cardiology (ACC) in Chicago.

9 Apr 2008

Malfunctioning kidneys may raise risk of sudden death in women

Women whose kidneys are poor at filtering impurities from the blood are at heightened risk of sudden cardiac death, according to a report published in Hypertension: Journal of the American Heart Association.

8 Apr 2008

Genetic variants of USF1 are associated with the increased risk for cardiovascular disease

Cardiovascular diseases (CVD) are major contributors to morbidity and mortality worldwide.

8 Apr 2008

Angina drug ranolazine shows promise for heart rhythm disorders

A recently approved angina drug may also represent a powerful new treatment for a rare hereditary syndrome that places teens at risk for sudden cardiac death, according to research presented at the 57th Annual Scientific Sessions of the American College of Cardiology (ACC) in Chicago.

1 Apr 2008

Beta-blockers heal the heart via the brain when administered during heart failure

Up to now, it was thought that beta-blockers work directly on the heart, but the new study shows that the drugs may also act via the brain, suggesting that future therapies to treat cardiovascular disease could be targeting the central nervous system.

26 Mar 2008

Cholesterol-associated gene variants can predict cardiovascular events

A study appearing in this week's New England Journal of Medicine confirms that a combination of gene variants previously associated with cholesterol levels does reflect patients' cholesterol levels and can signify increased risk of heart attack, stroke or sudden cardiac death.

20 Mar 2008

Implantable medical devices may expose patients to security, privacy risks; solutions suggested

Some medical devices such as implantable cardiac defibrillators and pacemakers are now equipped with wireless technology, allowing for remote device checks and freeing patients from repeated doctor visits.

13 Mar 2008

Doctors uncertain about approaches to care for heart failure patients

Less than one fourth of physicians specializing in geriatrics, internal or family medicine or cardiology believe they can accurately predict the whether patients with heart failure are at risk of dying, new Saint Louis University research found.

12 Feb 2008

Johns Hopkins to participate in 1000 Genomes Project

Researchers at the McKusick-Nathans Institute of Genetic Medicine (IGM) at Johns Hopkins will join other national and international scientists in the 1000 Genomes Project, an ambitious effort that will involve sequencing the genomes of numerous people from around the world to create the most detailed and medically useful picture to date of human genetic variation.

23 Jan 2008

Methadone and rare ventricular arrhythmia link

Methadone is a possible cause of sudden cardiac death even when it isn't overdosed but is taken at therapeutic levels primarily for relief of chronic pain or drug addiction withdrawal, a new study by Oregon Health & Science University researchers suggests.

10 Jan 2008

FDA to review potential anti-arrhythmic claims for Ranexa

CV Therapeutics, Inc. has announced that the U.S. Food and Drug Administration (FDA) has notified the Company that it will evaluate the approval of potential anti-arrhythmic claims for Ranexa (ranolazine extended-release tablets) as part of its ongoing review of the Company's supplemental new drug application (sNDA).

10 Dec 2007

Questions raised over the safety of the long-term use of the birth control pill

New research has again raised concerns about the safety of the long-term use of the birth control pill.

7 Nov 2007

Lives are saved when defibrillators are placed in public spaces

Heart experts at Johns Hopkins and elsewhere have evidence that at least 522 lives can be saved annually in the United States and Canada by the widespread placement of automated external defibrillators, the paddle-fitted, electrical devices used to shock and revive people whose hearts have suddenly stopped beating.

6 Nov 2007

Supplements do not reduce cancer risk

Most experts agree that supplements add little, if anything, to a well-balanced diet.

2 Nov 2007

When it comes to treatment for heart attacks white men get a better deal

Researchers at Duke University Medical Center (DCRI) in the United States say there is disparity in the treatment men and women receive for heart failure in hospitals.

4 Oct 2007

Heart disease of the left main coronary artery is often an inherited condition that clusters in families

Moreover, they discovered that initially healthy siblings of a person with the condition were 2.5 times more likely to go on to develop some form of heart disease than were siblings of a patient with heart disease that did not relate to the left main coronary artery.

4 Oct 2007

Call for food industry to phase trans fats out of their products

Experts on nutrition and public health are calling on leaders in the food industry to speed up the elimination of industrially produced trans fatty acids from the foods they produce and distribute, and to become partners in promoting healthy diets throughout the Americas.

27 Sep 2007

Call for more genetic research in the sport and exercise sciences

Genetic research into athletic ability should be encouraged for its potential benefits in both sport and public health, a leading group of scientists meeting at the University of Bath said today.

13 Sep 2007

Survey to evaluate arrhythmia rate in so-called high-risk MI patients

Sudden cardiac death is the leading cause of mortality in European and North-American countries. Studies have been attempting to identify the right population of patients at high risk of Sudden Cardiac Death ever since the introduction of the Implantable Cardioverter Defibrillators (ICD).

2 Sep 2007